Cerevel Therapeutics Inc... (CERE)

AI Score

Unlock

44.96

0.33 (0.74%)

At close: Jul 31, 2024, 8:00 PM

Cerevel Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q1 2019	Q2 2016	Q1 2016
Period Ending	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Mar 31, 2019	May 31, 2016	Feb 29, 2016
Cash & Equivalents	320.44M	990.97M	155.72M	175.76M	153.82M	136.52M	248.6M	138.22M	91.76M	193.02M	669.68M	327.06M	343.29M	383.62M	12.81M	17.97M	47.54M	79.55M	-95.44M	4.15M	5.78M
Short-Term Investments	525.86M	574.5M	521.16M	560.66M	673.17M	755.51M	741.32M	392.99M	451.18M	372.67M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	190.89M	n/a	n/a
Long-Term Investments	218.59M	187.16M	81.34M	88.64M	36.05M	58.13M	39.86M	1.87M	7.93M	52.27M	4.2M	4.2M	4.2M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	4.58M	3.43M	5.64M	5.78M	5.08M	4.76M	4.66M	2.76M	4.41M	6.93M	2.27M	3.1M	2.31M	6.09M	9.81M	5.01M	7.09M	6.24M	-95.44M	180K	175K
Receivables	4.96M	5.29M	3.41M	4.13M	3.2M	n/a	824K	981K	602K	729K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	384K	813K
Inventory	8.24M	n/a	-3.41M	-4.13M	-3.2M	-2.05M	7.58M	6.85M	9.71M	-729K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	8.32M	10.68M	7.5M	11.11M	10.59M	13.62M	7.92M	7.95M	10M	12.33M	5.35M	4.72M	6.52M	6.94M	3.08M	3.93M	6.71M	7.53M	n/a	869K	662K
Total Current Assets	859.58M	1.01B	687.79M	751.67M	840.78M	905.65M	998.66M	540.14M	553.55M	578.02M	675.03M	331.78M	349.81M	390.56M	15.88M	21.89M	54.25M	87.08M	95.44M	5.41M	7.25M
Property-Plant & Equipment	44.6M	45.77M	47.19M	48.26M	48.44M	49.29M	50.53M	51.89M	52.66M	51.7M	51.98M	51.92M	51.78M	48.62M	41.35M	34.98M	32.69M	27.49M	n/a	1.16M	1.21M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	267.77M	236.36M	134.18M	142.68M	89.56M	112.17M	95.05M	56.52M	65M	110.9M	58.45M	59.22M	58.29M	54.71M	51.15M	39.99M	39.79M	33.73M	-95.44M	1.34M	1.39M
Total Assets	1.13B	1.24B	821.96M	894.35M	930.35M	1.02B	1.09B	596.66M	618.55M	688.92M	733.48M	391M	408.1M	445.27M	67.04M	61.88M	94.04M	120.81M	n/a	6.74M	8.64M
Account Payables	10.84M	11.86M	11.54M	9.39M	7.32M	10.06M	14.97M	11.01M	8.18M	11.3M	5.45M	4.99M	7.75M	4.99M	4.82M	8.88M	8.31M	2.11M	n/a	2.36M	1.99M
Deferred Revenue	-3.52M	n/a	n/a	n/a	n/a	n/a	n/a	42.17M	n/a	28.43M	22.59M	21.7M	24.1M	22.25M	21.84M	n/a	n/a	n/a	n/a	366K	608K
Short-Term Debt	3.52M	3.4M	3.28M	3.15M	3.03M	2.9M	2.79M	2.67M	2.56M	2.44M	2.33M	2.24M	2.14M	n/a	2.21M	n/a	n/a	n/a	n/a	466K	439K
Other Current Liabilities	69.75M	76.91M	64.02M	53.02M	52.61M	59.6M	42.26M	43.06M	24.57M	28.8M	23.02M	22.04M	24.26M	24.55M	22.18M	13.89M	14.61M	12.77M	n/a	-448K	-421K
Total Current Liabilities	84.1M	92.18M	78.84M	65.56M	62.96M	72.56M	60.02M	56.74M	35.32M	42.54M	30.8M	29.26M	34.15M	29.55M	29.21M	22.77M	22.91M	14.88M	n/a	2.75M	2.62M
Long-Term Debt	364.79M	365.21M	365.61M	365.98M	366.34M	366.67M	366.95M	32.69M	33.41M	34.11M	34.75M	32.91M	32.95M	30.97M	29.52M	25.04M	25.54M	25.82M	n/a	43K	47K
Other Long-Term Liabilities	114M	112.16M	104.56M	112.31M	69.34M	57.35M	63.38M	54.41M	28.33M	33.54M	38.85M	34.95M	965K	236K	-24.28M	9.78M	18M	2.29M	n/a	n/a	n/a
Total Long-Term Liabilities	478.78M	477.37M	470.16M	478.29M	435.68M	424.02M	430.33M	87.1M	61.73M	67.65M	73.6M	67.86M	33.92M	31.2M	38.58M	34.82M	43.54M	28.11M	n/a	86K	94K
Total Liabilities	562.89M	569.55M	549M	543.85M	498.64M	496.58M	490.35M	143.84M	97.05M	110.19M	104.4M	97.12M	68.07M	60.75M	67.78M	57.59M	66.45M	42.98M	n/a	5.5M	6.11M
Total Debt	368.3M	480.78M	365.61M	365.98M	366.34M	366.67M	369.74M	35.36M	35.97M	36.55M	37.09M	35.14M	35.09M	33.01M	31.72M	25.04M	25.54M	25.82M	n/a	43K	47K
Common Stock	18K	18K	16K	16K	16K	16K	16K	15K	15K	15K	15K	13K	13K	13K	137.59M	1.00	n/a	6K	n/a	2.71M	3.44M
Retained Earnings	-1.53B	-1.4B	-1.27B	-1.17B	-1.07B	-967.75M	-874.95M	-775.01M	-684.54M	-616.24M	-557.19M	-495.13M	-441.89M	-390.91M	-3.12M	-324.22M	-297.51M	-244.3M	n/a	-338.04M	-336.53M
Comprehensive Income	-1.09M	1.77M	1.68M	1.14M	3.69M	3.1M	5.19M	7.99M	-1.33M	-986K	-533K	n/a	0.00	n/a	-267.25K	0.00	n/a	n/a	-77.38M	794K	887K
Shareholders Equity	564.46M	673.75M	272.96M	350.5M	431.71M	521.24M	603.36M	452.81M	521.5M	578.73M	629.08M	293.89M	340.04M	384.52M	-747K	4.29M	27.59M	77.82M	99.69M	1.24M	2.53M
Total Investments	744.45M	187.16M	521.16M	560.66M	673.17M	813.63M	781.18M	392.99M	459.11M	424.94M	4.2M	4.2M	4.2M	n/a	n/a	n/a	n/a	n/a	190.89M	n/a	n/a